Chemical activators of Olr1155 include a variety of compounds that influence intracellular signaling pathways leading to the activation of this protein. Forskolin is known to directly stimulate adenylate cyclase, thereby increasing the levels of cAMP within the cell. This rise in cAMP activates protein kinase A (PKA), which can phosphorylate target proteins such as Olr1155, leading to their activation. Similarly, Dibutyryl cAMP, a membrane-permeable cAMP analog, serves to activate PKA, potentially resulting in the phosphorylation and activation of Olr1155. Isoproterenol, a beta-adrenergic agonist, also elevates cAMP levels and activates PKA, offering another route to Olr1155 activation. Additionally, IBMX, a nonspecific inhibitor of phosphodiesterases, prevents the breakdown of cAMP, thus sustaining PKA activation and possibly leading to the phosphorylation and consequent activation of Olr1155.
On a different front, Ionomycin and A23187, both calcium ionophores, increase intracellular calcium concentrations, which can activate a range of calcium-dependent enzymes and kinases that may target Olr1155 for activation. Thapsigargin, by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), also causes a rise in cytosolic calcium levels, potentially leading to the activation of Olr1155 through similar calcium-dependent mechanisms. Phorbol 12-myristate 13-acetate (PMA) serves as an activator of protein kinase C (PKC), which can phosphorylate Olr1155, resulting in its activation. Zinc sulfate, an essential trace element, can act as a cofactor for various enzymes and may also participate in the phosphorylation of Olr1155 through activation of kinases. FPL 64176 and BAY K8644, which modulate L-type calcium channels, can indirectly increase intracellular calcium and activate Olr1155 through downstream kinase signaling pathways. Anandamide influences cannabinoid receptor-mediated signaling, which involves various kinases that can phosphorylate and activate Olr1155. Each of these chemicals plays a role in modulating specific cellular pathways that converge on the activation of Olr1155, highlighting the complex interplay of intracellular signaling in protein regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which may activate Olr1155 through calcium-sensitive pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate Olr1155, resulting in its activation. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acts as a signaling molecule or cofactor for kinases that may phosphorylate and activate Olr1155. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176 modulates L-type calcium channels, potentially increasing calcium influx and activating Olr1155 through calcium-dependent kinases. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 stimulates L-type calcium channels, which might lead to the activation of Olr1155 by altering calcium-mediated signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cAMP analog that activates PKA which in turn can phosphorylate and activate Olr1155. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts on beta-adrenergic receptors to increase cAMP and can activate Olr1155 by PKA-mediated phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases leading to increased cAMP, which may activate Olr1155 through PKA phosphorylation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA leading to increased cytosolic calcium that can activate Olr1155 via calcium-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, potentially leading to the activation of Olr1155 through kinase pathways. | ||||||